Table 5. Effect of folate and thymidine on sensitivity of T. brucei to DHFR-TS inhibitors in vitro.
Inhibitor | No addition | + Thymidine | + Folate | + Thymidine + Folate |
---|---|---|---|---|
Methotrexate | 0.012 ± 0.001 | 0.12 ± 0.03 | 1.31 ± 0.13 | 8.16 ± 2.78 |
Trimetrexate | 0.32 ± 0.02 | 2.82 ± 0.36 | 1.23 ± 0.06 | 4.09 ± 0.35 |
Pyrimethamine | 2.26 ± 0.32 | 2.01 ± 0.34 | 6.32 ± 0.71 | 6.87 ± 0.33 |
Trimethoprim | 48.8 ± 3.7 | 59.8 ± 8.6 | 170 ± 28 | 145 ± 22 |
Raltitrexed | 0.038 ± 0.001 | > 250 | 64.8 ± 4.3 | > 250 |
Pemetrexed | 0.020 ± 0.001 | > 250 | 12.9 ± 1.1 | >250 |
Nolatrexed | 33.8 ± 3.7 | 32.7 ± 4.7 | 21.8 ± 2.0 | 39.6 ± 7.2 |
Cells were cultured in TBM with the addition of thymidine (160 μM) and/or folate (9 μM) as described in Experimental section. Units for EC50 values are μM. Results are the weighted means ± standard error of 3 independent experiments